Cardiometabolic Risk and Metabolic Syndrome

       最近的研究指出代谢紊乱是导致心血管疾病重要的致病因素。内脏性肥胖，致动脉粥样硬化异常脂血症，血压升高，血糖代谢障碍等代谢综合症常见的症状都是心血管疾病的危险因素。有效地控制代谢综合症，减少可以致病的危险因素既是心血管疾病的预防方法也是治疗手段。CMBI特别报道的第179期是关于代谢综合征的报道，大家可以一并参考。更多文献，请用相关关键词通过CMBI文献查询获取。

• cv-risk-Cardiometabolic Risk-Are there specific treatments for the metabolic syndrome
• cv-risk-Cardiometabolic Risk-Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance
• cv-risk-Cardiometabolic Risk-Impact of Cardiometabolic Risk Factor Clusters on Health-related Quality of Life in the U.S.
• cv-risk-Cardiometabolic Risk-Insulin Resistance and Clustering of Cardiometabolic Risk Factors in Urban Teenagers in Southern India
• cv-risk-Cardiometabolic Risk-Obesity and cardiometabolic syndrome in children
• cv-risk-Cardiometabolic Risk-Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome
• cv-risk-Cardiometabolic Risk-The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome
• cv-risk-Cardiometabolic Risk-Waist Circumference and Cardiometabolic Risk
• cv-risk-Cardiometabolic Risk-Waist Circumference and Cardiometabolic Risk-1
• cv-The Endocannabinoid System-A New Target for Cardiometabolic Risk Reduction-A Cardiologist’s Perspective on Cardiometabolic Risk
• cv-The Endocannabinoid System-A New Target for Cardiometabolic Risk Reduction-Cannabinoid-1 Receptor Blockade in Cardiometabolic Risk Reduction
• cv-The Endocannabinoid System-A New Target for Cardiometabolic Risk Reduction-Cannabinoid-1 Receptor Blockade in Cardiometabolic Risk Reduction-Safety, Tolerability, and Therapeutic Potential
• cv-The Endocannabinoid System-A New Target for Cardiometabolic Risk Reduction-Introduction
• cv-The Endocannabinoid System-A New Target for Cardiometabolic Risk Reduction-The Endocannabinoid System in the Regulation of Cardiometabolic Risk Factors
• cv-The Endocannabinoid System-A New Target for Cardiometabolic Risk Reduction-Weight Reduction and Cardiovascular and Metabolic Disease Prevention
• cv-risk-Cardiometabolic Risk-A Cardiologist’s Perspective on Cardiometabolic Risk
• cv-risk-Cardiometabolic Risk-Abdominal Adiposity and Cardiometabolic Risk
• cv-risk-Cardiometabolic Risk-Abdominal Obesity-Role in the Pathophysiology of Metabolic Disease and Cardiovascular Risk
• cv-risk-Cardiometabolic Risk-Cannabinoid-1 Receptor Blockade in Cardiometabolic Risk Reduction
• cv-risk-Cardiometabolic Risk-Cannabinoid-1 Receptor Blockade in Cardiometabolic Risk Reduction-2
• cv-risk-Cardiometabolic Risk-Cardiovascular and Metabolic Risk Factors
• cv-risk-Cardiometabolic Risk-Effect of Insulin Resistance, Dyslipidemia, and Intra-abdominal Adiposity on the Development of Cardiovascular Disease and Diabetes Mellitus
• cv-risk-Cardiometabolic Risk-Endocannabinoid System in the Regulation of Cardiometabolic Risk Factors
• cv-risk-Cardiometabolic Risk-Introduction
• cv-risk-Cardiometabolic Risk-Multiple Risk Factors for Cardiovascular Disease and Diabetes Mellitus
• cv-risk-Cardiometabolic Risk-Role of the Endocannabinoid System in Regulating Cardiovascular and Metabolic Risk Factors
• cv-risk-Cardiometabolic Risk-Therapeutic Options for Modifying Cardiometabolic Risk Factors
• cv-risk-Cardiometabolic Risk-Understanding Metabolic Homeostasis and Imbalance
• cv-risk-Cardiometabolic Risk-Weight Reduction and Cardiovascular and Metabolic Disease Prevention
• cv-risk-Cardiometabolic Risk-What Is the Potential Role of Cannabinoid-1 Receptor Blockade in Glucose and Lipid Management
• cv-cardiometabolic risk-Check Up America-Reduce Cardiometabolic Risk. Clinical Tools of the American Diabetes Association
• cv-cardiometabolic risk-Managing Cardiometabolic Risk
• cv-cardiometabolic risk-The Endocannabinoid System-A New Target for the Regulation of Energy Balance and Metabolism
• cv-Increasing Prevalence of Obesity and Clustered Cardiometabolic Risk-Can Treatment of the Underlying Cause Reverse the Trends
• cv-Managing Cardiometabolic Risk-Abdominal Adiposity and Cardiometabolic Risk
• cv-Managing Cardiometabolic Risk-Cardiovascular and Metabolic Risk Factors
• cv-Managing Cardiometabolic Risk-Managing Cardiometabolic Risk-Introduction
• cv-Managing Cardiometabolic Risk-Understanding Metabolic Homeostasis and Imbalanc
• cv-Managing Cardiometabolic Risk-What Is the Potential Role of Cannabinoid-1 Receptor Blockade in Glucose and Lipid Managemen
• cv-risk-Managing Cardiometabolic Risk
• cv-clin-metabolic syndrome-Age-specific change of prevalence of metabolic syndrome
• cv-clin-metabolic syndrome-Circulating leptin levels predict the development of metabolic syndrome in middle-aged men
• cv-clin-metabolic syndrome-Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women
• cv-clin-metabolic syndrome-Clustering of metabolic syndrome risk factors and arterial stiffness in young adults
• cv-clin-metabolic syndrome-Defining the metabolic syndrome
• cv-clin-metabolic syndrome-Development of Age-Specific Adolescent Metabolic Syndrome Criteria That Are Linked to the Adult Treatment Panel III and International Diabetes Federation Criteria
• cv-clin-metabolic syndrome-Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Middle-Aged and Older Chinese People
• cv-clin-metabolic syndrome-Effect of PPAR-γ Agonist on Adiponectin Levels in the Metabolic Syndrome
• cv-clin-metabolic syndrome-Effects of telmisartan on fat distribution in individuals with the metabolic syndrome
• cv-clin-metabolic syndrome-Elevated Lp-PLA2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects
• cv-clin-metabolic syndrome-Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome
• cv-clin-metabolic syndrome-Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects
• cv-clin-metabolic syndrome-How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population
• cv-clin-metabolic syndrome-Impact of metabolic syndrome on clinical and angiographic outcome after sirolimus-eluting stent implantation.
• cv-clin-metabolic syndrome-Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary Lesions
• cv-clin-metabolic syndrome-Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome
• cv-clin-metabolic syndrome-Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients
• cv-clin-metabolic syndrome-Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
• cv-clin-metabolic syndrome-Metabolic syndrome in a sub-Saharan African setting
• cv-clin-metabolic syndrome-Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study
• cv-clin-metabolic syndrome-Modulation of aortic vascular reactivity by sex hormones in a male rat model of metabolic syndrome
• cv-clin-metabolic syndrome-Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness
• cv-clin-metabolic syndrome-Prognostic Relevance of Metabolic Syndrome in Hypertensive Patients at Low-to-Medium Risk
• cv-clin-metabolic syndrome-The metabolic syndrome and nonfatal ischemic heart disease; a population-based study
• cv-Metabolic syndrome and blood pressure
• cv-Metabolic syndrome, dysglycaemia and vascular disease
• cv-metabolic syndrome, the Guy syndrome and the hypofit syndrome
• cv-metabolic syndrome.-Milk and the metabolic syndrome
• cv-Metabolic Syndrome-A Complex Web of Risks for Metabolic Syndrome
• cv-metabolic syndrome-Alpha-lipoic acid-physiologic mechanisms and indications for the treatment of metabolic syndrome
• cv-Metabolic syndrome-and mitochondrial function
• cv-Metabolic Syndrome-Diagnosis and Management of the Metabolic Syndrome-An American Heart Association
• cv-Metabolic Syndrome-Dietary Intake and the Development of the Metabolic Syndrome
• cv-Metabolic Syndrome-Ezetimibe and Simvastatin Reduce Inflammation, Disease Activity, and Aortic Stiffness and Improve Endothelial Function in Rheumatoid Arthritis
• cv-metabolic syndrome-FXR-a promising target for the metabolic syndrome
• cv-metabolic syndrome-Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome
• cv-metabolic syndrome-Genetic determinants of C-reactive protein levels in metabolic syndrome
• cv-Metabolic syndrome-Metabolic syndrome and mortality in stable coronary heart disease-Relation to gender
• cv-Metabolic syndrome-Metabolic syndrome as a risk factor for coronary heart disease and stroke
• cv-Metabolic Syndrome-Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery
• cv-Metabolic Syndrome-Prevalence of Metabolic Syndrome in Young Men in Japan
• cv-Metabolic syndrome-Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics
• cv-metabolic syndrome-The predictive adaptive response and metabolic syndrome
• cv-metabolic syndrome-The sympathetic nervous system and the metabolic syndrome